Oracle Investment Management as of Sept. 30, 2015
Portfolio Holdings for Oracle Investment Management
Oracle Investment Management holds 25 positions in its portfolio as reported in the September 2015 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Accelr8 Technology Corporation | 18.0 | $88M | 5.4M | 16.18 | |
| NxStage Medical | 11.2 | $55M | 3.5M | 15.77 | |
| Quidel Corporation | 10.9 | $53M | 2.8M | 18.88 | |
| Chimerix (CMRX) | 7.7 | $38M | 986k | 38.20 | |
| Opko Health (OPK) | 6.9 | $34M | 4.0M | 8.41 | |
| Mazor Robotics Ltd. equities | 5.6 | $28M | 2.5M | 11.03 | |
| Intrexon | 5.2 | $26M | 805k | 31.80 | |
| Acorda Therapeutics | 4.4 | $22M | 816k | 26.51 | |
| Tesaro | 4.0 | $20M | 494k | 40.10 | |
| Vermillion | 3.5 | $17M | 8.6M | 2.00 | |
| Hansen Medical | 3.5 | $17M | 4.5M | 3.76 | |
| shares Agenus | 3.1 | $15M | 3.3M | 4.60 | |
| Accuray Incorporated (ARAY) | 2.9 | $14M | 2.9M | 4.99 | |
| Pacific Biosciences of California (PACB) | 2.4 | $12M | 3.2M | 3.66 | |
| Amarin Corporation (AMRN) | 2.4 | $12M | 6.1M | 1.93 | |
| WebMD Health | 1.9 | $9.5M | 238k | 39.84 | |
| Biolase Technology | 1.9 | $9.4M | 11M | 0.90 | |
| Transition Therapeutics | 1.4 | $7.1M | 4.0M | 1.79 | |
| Contrafect | 1.1 | $5.3M | 1.2M | 4.45 | |
| Regulus Therapeutics | 0.5 | $2.4M | 375k | 6.54 | |
| Biogen Idec (BIIB) | 0.5 | $2.2M | 7.7k | 291.08 | |
| Metabolix | 0.3 | $1.3M | 958k | 1.38 | |
| ZIOPHARM Oncology | 0.2 | $1.2M | 134k | 9.01 | |
| Second Sight Med Prods | 0.2 | $1.2M | 203k | 5.93 | |
| Thoratec Corporation | 0.1 | $316k | 5.0k | 63.20 |
